Article
Paris-Neurotech will collaborate with INSERM, the French National Institute for Health and Medical Research, to develop a technology platform and therapies for retinal diseases.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.